China clamps down on small-cap U.S. listings by Chinese issuers; China mandates personal information protection compliance audits for companies; and AI company loses against Reuters in U.S. summary judgment with key implication
Philip Qu of TransAsia Lawyers analyze regulatory and statutory progress in China’s ever flourishing TMT sector in 2024, and look at the outlook for 2025
Trump signs memorandum to restrict investments that do not serve American interests; A Jiangsu court ruled that investments in overseas crypto projects are not protected under Chinese law; and Chinese companies raise funds in hope of easing of regulations against private enterprises
Chinese regulatory support to China originated-biopharma companies is going global. Wu Ting, partner of the Life Sciences and Healthcare Practice at Haiwen & Partners examines the implications
Chinese EV maker Geely expands into Brazil through a partnership with France’s Renault; The parent company of Calvin Klein and Tommy Hilfiger is blacklisted by China; and Canadian Solar is sued by China’s Trina Solar over patent infringement.
China increases regulatory framework for the pharma and life sciences sectors; Chinese authorities intervene to regulate VC funds management; and internet content providers could face stricter scrutiny on military-related content.
The sudden rise of DeepSeek AI has prompted regulators’ concerns over its processing of data; the EU plans to ensure e-commerce platforms are compliant with its laws; and U.S.-China tensions are pushing China-focused private equity funds to expand beyond China.
Data platforms that look into supply chains benefit from worsening U.S.-China trade relations; China issues first comprehensive guidelines on anti-corruption compliance for the healthcare sector; and complaints have been filed against TikTok, Shein, and AliExpress alleging they are transferring EU personal data to Chinese authorities in violation of GDPR rules.
